PhRMA

DECEMBER 15, 2022

Yet another study highlights the unintended consequences of the 340B program, which is increasing costs for patients and the health care system as a whole. In this case, the Berkeley Research Group (BRG) found that nearly 36% of all Medicare Part B therapy sales occurred at 340B hospitals in 2021 , up nearly 17 percentage points since 2012, meaning care is moving from physician offices and non-340B hospitals to 340B hospitals.

Hospitals 286

Hospitals 286

Drug Topics

DECEMBER 13, 2022

Relyvrio is intended to slow the disease progression of amyotrophic lateral sclerosis.

FDA 201

FDA 201

STAT

DECEMBER 14, 2022

Hospice in America is gravely ill. An extensive investigation jointly published by The New Yorker and ProPublica documented outright fraud, predatory practices, and flagrant mistreatment by specific publicly traded and private equity-owned hospice companies.

Documentation 145

Documentation 145

Pharmacy Times

DECEMBER 12, 2022

Dapagliflozin (Farxiga) found effective in lowering the risk of hospitalization for patients with chronic kidney disease, with or without a diagnosis of type 2 diabetes, and increased the number of days alive and out of the hospital.

Hospitals 145

Hospitals 145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PhRMA

DECEMBER 14, 2022

A survey of more than 5,000 Americans conducted with Ipsos found that insured Americans want better health care coverage. These insights come from the third installment of the Patient Experience Survey and show how Americans favor policy solutions that improve their ability to navigate and access their care by seeking to remove barriers imposed by insurers and middlemen such as pharmacy benefit managers (PBMs).

Insurance 258

Insurance 258

Drug Topics

DECEMBER 12, 2022

When it comes to practicing pharmacy, do titles and degrees actually matter?

201

201

Fierce Healthcare

DECEMBER 16, 2022

2023 forecast: Health tech tools begin constructing the Alzheimer's treatment plan. aburky. Fri, 12/16/2022 - 17:17.

142

142

PhRMA

DECEMBER 14, 2022

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important decisions about patient access to health care based on their determination of the value of new tests and treatments.

225

225

Drug Topics

DECEMBER 14, 2022

Job satisfaction is down and workplace stress is on the rise.

201

201

STAT

DECEMBER 13, 2022

An experimental cancer vaccine being developed by the biotechnology firm Moderna and the drug giant Merck reduced the risk that melanoma would return after surgery or that patients would die by 44%, the company said. The data, made public in a press release, represent the first evidence of an effective individualized cancer vaccine based on mRNA, the technology used in the Covid shots.

Vaccines 144

Vaccines 144

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

DECEMBER 16, 2022

2023 forecast: Pharmacists push to take on a greater role in patient care. pminemyer. Fri, 12/16/2022 - 12:39.

Patient Care 142

Patient Care 142

PhRMA

DECEMBER 12, 2022

If you or a loved one were to receive a diagnosis of a serious or life-threatening disease, you would likely want access to a U.S. Food and Drug Administration (FDA) approved safe and effective medicine as soon as possible. That’s precisely why the accelerated approval pathway was created back in 1992 at the urging of patient advocates. Since then, it has been a lifeline for millions of patients.

FDA 224

FDA 224

Drug Topics

DECEMBER 12, 2022

Investigators set out to evaluate how medication access for certain rheumatic conditions has changed since June 2022.

200

200

STAT

DECEMBER 10, 2022

Whenever a hematopoietic cell transplant patient tries to get a family member to sneak food in past the nurses, Federico Stella, a resident hematologist at the University of Milan, remembers. One was a girl who tried to get her sister to bring her a panettone, a Milanese sweet bread usually eaten around the holidays. A week before Christmas, the sister tried to hide the panettone in a bag.

144

144

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

DECEMBER 12, 2022

House and Senate Dems want CMS to drop ACO REACH members due to fraud concerns. rking. Mon, 12/12/2022 - 16:08.

139

139

Pharmacy Times

DECEMBER 16, 2022

Merck and Moderna’s adjuvant melanoma treatment shows reduced risk of recurrence or death by 44% compared with pembrolizumab alone.

Vaccines 139

Vaccines 139

Drug Topics

DECEMBER 12, 2022

Online portals are accessible via tablet or computer and can streamline the mental health screening process.

191

191

STAT

DECEMBER 12, 2022

This Wednesday will mark two years since nurse Sandra Lindsay became the first person in the U.S. to receive a Covid-19 vaccine outside of a clinical trial. A study released Tuesday by the Commonwealth Fund shows that in those two years, the Covid vaccines have averted over 3 million deaths in the U.S. The Centers for Disease Control and Prevention estimates that more than 1 million Americans have died from Covid-19 since the onset of the pandemic.

Vaccines 144

Vaccines Hospitals Immunization 144

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

DECEMBER 11, 2022

Digital transformation in pharma is not a singular endeavour. It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. So, when a life sciences company embarks on a project of digital transformation or innovation, it’s really embarking on multiple projects that span the wide world of pharmaceutical operations.

Hospitals 137

Hospitals 137

Pharmacy Times

DECEMBER 14, 2022

Study finds gluten-free diets may play an important role in the causality of celiac disease on the development of psoriasis.

139

139

Drug Topics

DECEMBER 14, 2022

With the rise of cannabidiol (CBD) use, understanding how it can impact the effect of other medications is important.

187

187

STAT

DECEMBER 10, 2022

NEW ORLEANS — An emerging class of genetically targeted drugs is inducing remissions in about one-third of patients with advanced leukemia, according to updates Saturday from separate clinical trials. Two biotechs — Syndax Pharmaceuticals and Kura Oncology — are developing their own versions of so-called menin inhibitors that have the potential to become effective treatments for certain types of genetically defined acute myeloid leukemia (AML), a rapidly progressing bone mar

140

140

PharmExec

DECEMBER 14, 2022

Perspectives from a board member and an aspiring board member on how to increase the number of qualified women on boards.

136

136

Pharmacy Times

DECEMBER 15, 2022

Ryan Haumschild, PharmD, MS, MBA, leads a discussion surrounding myelodysplastic syndrome (MDS).

138

138

Drug Topics

DECEMBER 12, 2022

Haylea Hannah, MSPH, PhD, discusses her research on the barriers to medications for opioid use disorder that people who are incarcerated can face and what pharmacists can do to address the barriers.

187

187

Fierce Healthcare

DECEMBER 16, 2022

2023 forecast: 7 immediate and long-term priorities for hospital leaders. dmuoio. Fri, 12/16/2022 - 18:10.

Hospitals 131

Hospitals 131

Fierce Pharma

DECEMBER 13, 2022

Cancer center leaders lay bare CAR-T makers' struggles—and an unexpected laggard. aliu. Tue, 12/13/2022 - 20:12.

131

131

Pharmacy Times

DECEMBER 15, 2022

Medical experts provide an overview on potential risk factors leading to MDS.

132

132

Drug Topics

DECEMBER 13, 2022

By offering resources such as free samples and generic alternatives, pharmacists can help patients lower costs.

187

187

STAT

DECEMBER 10, 2022

NEW ORLEANS — Researchers had hoped in recent years that a protein called GPRC5D might offer a new way to get the immune system to hunt down and destroy multiple myeloma cells. Now, the results of a Phase 2 study on a bispecific antibody targeting this protein offers confirmation. The data, presented Saturday at the annual American Society of Hematology conferences, wowed a crowd of attendees, including clinicians who began excitedly imagining how to use the new drug in practice.

Immunization 128

Immunization 128

pharmaphorum

DECEMBER 16, 2022

CSL’s gene therapy for haemophilia B has been recommended for approval by the EMA’s human medicine committee, setting up a decision by the European Commission early next year. The positive opinion for etranacogene dezaparvovec – which was approved as Hemgenix by the FDA last month – raises the prospect of the first one-time therapy in the EU for the bleeding disorder, which affects around 1 in 50,000 of the population, according to the European Haemophilia Network (EUHANET).

FDA 126

FDA 126

Pharmacy Times

DECEMBER 13, 2022

Adagrasib (Krazati; Mirati Therapeutics, Inc) approved for adults with KRAS-G12C-mutated locally advanced or metastatic non-small cell lung cancer as determined by an FDA-approved test.

FDA 132

FDA 132

Drug Topics

DECEMBER 14, 2022

New pathways of care are needed to improve health care spending.

184

184